🇺🇸 FDA

Drug profile · INN

eplontersen sodium

WAINUA (AUTOINJECTOR)

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

eplontersen sodium (WAINUA (AUTOINJECTOR)) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

Key facts

INN eplontersen sodium
Brand WAINUA (AUTOINJECTOR)
Route SUBCUTANEOUS
Formulation SOLUTION

Frequently asked questions

What is eplontersen sodium?

eplontersen sodium (WAINUA (AUTOINJECTOR)) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

What is the brand name for eplontersen sodium?

WAINUA (AUTOINJECTOR) is a marketed brand name for eplontersen sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of eplontersen sodium?

eplontersen sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.